Found: 48
Select item for more details and to access through your institution.
Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 819, doi. 10.1002/ajh.24096
- By:
- Publication type:
- Article
Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. 282, doi. 10.1002/ajh.23923
- By:
- Publication type:
- Article
A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of L-Asparaginase Combined with Vincristine and Prednisolone on Acute Myeloblastic Leukemia (M0) Associated with Non-Hodgkin Lymphoma.
- Published in:
- Acta Haematologica, 2009, v. 122, n. 1, p. 54, doi. 10.1159/000243725
- By:
- Publication type:
- Article
Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 2, p. 96, doi. 10.1159/000521113
- By:
- Publication type:
- Article
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well‐controlled platelet counts.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 779, doi. 10.1111/ejh.13866
- By:
- Publication type:
- Article
Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.
- Published in:
- Internal Medicine, 2023, v. 62, n. 22, p. 3299, doi. 10.2169/internalmedicine.1611-23
- By:
- Publication type:
- Article
A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
- Published in:
- Molecular Genetics & Genomic Medicine, 2019, v. 7, n. 4, p. N.PAG, doi. 10.1002/mgg3.591
- By:
- Publication type:
- Article
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 60, doi. 10.1007/s12185-024-03758-4
- By:
- Publication type:
- Article
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 2, p. 210, doi. 10.1007/s12185-023-03606-x
- By:
- Publication type:
- Article
Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 5, p. 694, doi. 10.1007/s12185-023-03549-3
- By:
- Publication type:
- Article
Chronic myeloid leukemia: the cutting-edge evidence and things we should know.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib.
- Published in:
- Oncology Letters, 2017, v. 13, n. 5, p. 3803, doi. 10.3892/ol.2017.5920
- By:
- Publication type:
- Article
MPC-1 expression in myeloma cells is associated with the efficacy of bortezomib therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Plasma cell maturity as a predictor of prognosis in multiple myeloma.
- Published in:
- Medical Oncology, 2016, v. 33, n. 8, p. 1, doi. 10.1007/s12032-016-0803-3
- By:
- Publication type:
- Article
Potential role for second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis.
- Published in:
- Oncology Reports, 2019, v. 42, n. 6, p. 2836, doi. 10.3892/or.2019.7339
- By:
- Publication type:
- Article
Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.
- Published in:
- Oncology Reports, 2016, v. 36, n. 5, p. 2976, doi. 10.3892/or.2016.5110
- By:
- Publication type:
- Article
Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation.
- Published in:
- Cancer Cell International, 2016, v. 16, p. 1, doi. 10.1186/s12935-016-0314-5
- By:
- Publication type:
- Article
Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study Group
- Published in:
- Oncology, 2018, v. 94, n. 2, p. 85, doi. 10.1159/000481945
- By:
- Publication type:
- Article
Thrombopoietin Levels During Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 9, p. 813, doi. 10.1007/s40261-018-0670-0
- By:
- Publication type:
- Article
Induced Differentiation of Human Myeloid Leukemia Cells into M2 Macrophages by Combined Treatment with Retinoic Acid and 1α,25-Dihydroxyvitamin D<sub>3</sub>.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113722
- By:
- Publication type:
- Article
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
- Published in:
- International Journal of Hematology, 2015, v. 101, n. 6, p. 585, doi. 10.1007/s12185-015-1780-6
- By:
- Publication type:
- Article
The European Treatment and Outcome Study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid leukemia.
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 4, p. 379, doi. 10.1007/s12185-014-1649-0
- By:
- Publication type:
- Article
Erratum to: An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- Correction notice
Successful treatment of Hodgkin lymphoma in second trimester of pregnancy: feasibility of ABVD regimen.
- Published in:
- 2011
- By:
- Publication type:
- journal article
An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 11, p. 2081, doi. 10.1007/s00277-018-3412-8
- By:
- Publication type:
- Article
Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 6, p. 957, doi. 10.1007/s00277-014-2013-4
- By:
- Publication type:
- Article
Clinical impact of central nervous system‐directed therapies on intravascular large B‐cell lymphoma: A single institution's experience.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 467, doi. 10.1002/jha2.380
- By:
- Publication type:
- Article
Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes.
- Published in:
- Cancer Science, 2020, v. 111, n. 6, p. 2132, doi. 10.1111/cas.14419
- By:
- Publication type:
- Article
Efficacy and safety of antifungal prophylaxis with oral itraconazole solution among patients receiving corticosteroids: who should be given prophylaxis?
- Published in:
- Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2011, v. 17, n. 6, p. 744, doi. 10.1007/s10156-011-0251-0
- By:
- Publication type:
- Article
Pirarubicin‐based intensive chemotherapy followed by consolidative high‐dose chemotherapies for peripheral T‐cell lymphomas: A noncomparative phase 2 study.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 1094, doi. 10.1002/hon.3043
- By:
- Publication type:
- Article
Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis.
- Published in:
- 2019
- By:
- Publication type:
- clinical trial
The EUTOS long‐term survival score predicts disease‐specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice‐based cohort.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8931, doi. 10.1002/cam4.3516
- By:
- Publication type:
- Article
Speciation of arsenic trioxide metabolites in blood cells and plasma of a patient with acute promyelocytic leukemia.
- Published in:
- Analytical & Bioanalytical Chemistry, 2009, v. 393, n. 2, p. 689, doi. 10.1007/s00216-008-2487-9
- By:
- Publication type:
- Article
Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 7, p. 1079, doi. 10.1007/s00432-010-0973-x
- By:
- Publication type:
- Article
Efficacy of Oral Cytarabine Ocfosfate and Etoposide in the Treatment of Elderly Patients with Higher-Risk Myelodysplastic Syndromes Compared to That in Elderly Acute Myeloid Leukemia Patients.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 59, n. 2, p. 152, doi. 10.1159/000351114
- By:
- Publication type:
- Article
Direct effect of dasatinib on signal transduction pathways associated with a rapid mobilization of cytotoxic lymphocytes.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 11, p. 3223, doi. 10.1002/cam4.925
- By:
- Publication type:
- Article
A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment.
- Published in:
- Clinics & Practice, 2024, v. 14, n. 4, p. 1216, doi. 10.3390/clinpract14040097
- By:
- Publication type:
- Article
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient.
- Published in:
- Journal of Hematology & Oncology, 2012, v. 5, n. 1, p. 1, doi. 10.1186/1756-8722-5-1
- By:
- Publication type:
- Article
Intravascular Large B-Cell Lymphoma of the Uterus: A Case with Favorable Clinical Outcome.
- Published in:
- International Journal of Surgical Pathology, 2011, v. 19, n. 5, p. 672, doi. 10.1177/1066896909346273
- By:
- Publication type:
- Article
Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A.
- Published in:
- Cancer Cell International, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12935-015-0176-2
- By:
- Publication type:
- Article